Explorys EHR solutions
Tracking visceral fat reduction over the course of Semaglutide therapy is one of the most clinically meaningful ways to measure treatment efficacy
A single lever may not be enough for chronic pain
Semaglutide helps to reduce appetite, increase feelings of fullness, and regulate blood sugar levels
Semaglutide or Tirzepatide, cannot be prescribed and should not be purchased by individuals with a BMI under 25, an eating disorder, diabetes, gallbladder disease, history of drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer or a family history of it, diabetic retinopathy, multiple endocrine neoplasia type 2, or those who are pregnant, breastfeeding, or planning to become pregnant
Several factors create and amplify misinformation about weight loss medications